Healthcare and Health in the Philippines

As of 2026-08-31 · Updated 2026-08-31 · Section: Society, Human Rights & Public Safety · 日本語版

0. The essentials in 30 seconds

1. The framework — the Universal Health Care Act (RA 11223)

Republic Act No. 11223 (the Universal Health Care Act) was passed in 2019. It automatically enrolls every Filipino citizen as a member of PhilHealth (the Philippine Health Insurance Corporation), consolidates province-wide/city-wide health systems, establishes primary care as a gatekeeper function, and reforms payment methods.

Membership categories

注 Free enrollment for senior citizens applies to "Filipino citizens." Foreign senior citizens are not subject to the mandatory enrollment provisions of the Expanded Senior Citizens Act (see Chapter 11 below).

2. PhilHealth — premium contributions (2026)

  2026 premium rate = 5.00% of monthly basic salary
     Floor: monthly income ≤ ₱10,000    → flat ₱500
     Range: ₱10,000.01–99,999.99         → 5% of income
     Ceiling: monthly income ≥ ₱100,000  → flat ₱5,000

  Employees split 2.5% each with their employer (at the floor: ₱250 + ₱250)
  Self-employed / professionals / OFWs pay the full 5% themselves
  RA 11223 Section 10's phased increases start at 2.75% in 2019 and
    top out at 5% (income ceiling ₱100,000) in 2024 → no increase in 2026

(Source: Philippine Information Agency, "PhilHealth sets 5% premium contribution rate for 2026")

注 Correction made after re-checking the statute on 2026-08-26. The schedule set out in RA 11223, Section 10 (Premium Contributions) ends at "2019: 2.75% / 2020: 3.00% / 2021: 3.50% / 2022: 4.00% / 2023: 4.50% / 2024: 5.00% / 2025: 5.00%" — there is no line in the statute for "2026." The income ceiling likewise reaches ₱100,000 in 2024 and stops there. Accordingly, the 5% rate for 2026 is not "the 2026 line of the statute," but a continuation of the previous year's rate as set out in a PhilHealth advisory dated 6 May 2026. Writing "RA 11223 Section 10 sets 2026 at 5%" would be a misreading of the statute (sources: RA 11223 Section 10 as published on LawPhil, https://lawphil.net/statutes/repacts/ra2019/ra_11223_2019.html; PIA reporting, 2026). Note also that as of August 2026, no amendatory Republic Act to RA 11223 exists. The House of Representatives passed a UHC Act amendment bill in February 2025, but it has not become law (House passage is not the same as enactment). 注However, note that PhilHealth's founding law is RA 7875, and RA 11223 is a major amendment to it — this distinction is already documented in a separate resource (Field 15).

Delinquency interest: 1.5% per month for self-employed members and land-based OFWs; 3% per month for employers and sea-based OFWs. Employers remit the following month via the EPRS (Electronic Premium Remittance System).

注 "Paying your premiums" does not mean "free hospital bills." PhilHealth pays a portion of the claim to the hospital; the remainder becomes the patient's out-of-pocket responsibility (see Chapter 4).

3. The 2024 transfer of funds to the treasury and the Supreme Court ruling (5 December 2025)

This was the single biggest point of contention in Philippine health policy from 2024 through 2026. Because readers often misunderstand it, it is covered in detail here.

What happened

Key points of the ruling

• It ordered the ₱60 billion returned to PhilHealth, and permanently barred the transfer of the remaining ₱29.9 billion.
• Special Provision 1(d) of the 2024 GAA and DOF Circular 003-2024 were declared void as a grave abuse of discretion (majority opinion).
• Special Provision 1(d) amounted to a "rider" unrelated to the purpose of an appropriations bill.
• The government's argument of "idle funds" was rejected. Even surplus funds are, by law, reserved for improving benefits, lowering premiums, and covering contingent liabilities.
• It conflicts with the "sin tax" laws (which earmark excise taxes on alcohol, tobacco, and sugar-sweetened beverages for UHC).
• If lawmakers want to change the UHC Act, they should do so through dedicated legislation, not a budget law.

(Sources: Supreme Court press briefing, 5 December 2025; Rappler; Philstar; Inquirer)

Aftermath — reflected in the 2026 budget

注 The national government subsidy to PhilHealth in 2025 was zero. Congress removed the entire subsidy, arguing that PhilHealth already held roughly ₱500 billion in surplus reserves and was slow to expand benefits. In 2026, the process took an unusual path — from a ₱5.3 billion proposal in the executive budget to ₱129.8 billion approved by Congress.

注 The origin of each figure matters. The "₱500 billion surplus" is Congress's claim, "even with zero subsidy there is a ₱150 billion surplus" is DOH's explanation, and "a ₱356.6 billion reserve shortfall for 2023–2025" is a critical estimate by UP medical school professor Antonio Dans and colleagues. None of these are confirmed official government statistics.

Additional note: In July 2026, PCSO (the Philippine Charity Sweepstakes Office) approved an additional ₱1.6 billion contribution to PhilHealth (Philstar, 30 July 2026).

4. The reality of out-of-pocket spending — by the numbers

National health spending (2024, PSA National Health Accounts / PNHA, published 24 July 2025)

2024 was reported as the first year in which the government's share (44.7%) exceeded household out-of-pocket spending (42.7%) (Manila Standard, 2025). Note, however, that the absolute amount of out-of-pocket spending is still rising.

Why out-of-pocket spending remains high

  PhilHealth pays hospitals under "All Case Rates" — a flat, fixed amount per case.
     Example: pneumonia ₱29,250, caesarean section ₱37,050,
     cholecystectomy ₱60,450 (after the January 2025 revision)

  Whatever the actual bill exceeds the case rate becomes the patient's burden.
  At private hospitals, the case rate almost never covers the full bill.

  At accredited facilities, the case rate is deducted directly from the
    hospital bill at discharge (there is no need to submit receipts
    afterward for reimbursement).

According to DOH, PhilHealth currently covers only 14–15% of a patient's hospital bill, on average. The goal is to raise this to 25–30% or more (PIA, 2026). 注 This figure is the single most important number for correcting the misconception that "enrollment means most of the bill is covered."

注 Outdated case rates

According to 2025 research by PIDS (the Philippine Institute for Development Studies), 99.9% of the 8,869 existing case rates had not been updated since 2013. The case rate for a normal delivery, ₱6,500, is worth only about ₱3,900 in 2023 real terms. 98.8% of claims exceeded their reimbursement amount.

→ A shift to DRG (Diagnosis-Related Groups) payment is planned for around 2027. "Shadow billing" (paying under case rates while simultaneously calculating what DRG would pay) has been in place since 2024. Data analysis is expected to be complete in Q4 2026; as of August 2026, 41 hospitals in Central Visayas are participating in the pilot. The classification software (grouper) is being developed based on Thailand's TCMC (Thai CaseMix Centre) system. (Sources: BusinessMirror, November 2025; Philstar/The Freeman, August 2026)

5. PhilHealth — benefit expansion (2024–2026)

Timeline of reforms

Major benefits (as of 2026)

注 As of 2026, lung cancer is not covered under the Z Benefit package. "Cancer is fully covered" is incorrect. 注 Z Benefits require pre-authorization and use of a contracted hospital. Within a package, services are in principle free of additional charge for a standard ward room.

YAKAP — the successor to Konsulta

注 The name "Konsulta" is no longer officially used. The former Konsulta program was renamed and expanded into YAKAP in July 2025. Registrants under the old Konsulta program were automatically migrated to YAKAP. Clinics have until 1 April 2026 to update their signage (Advisory 2025-0061). 注 Separately, the free EMR software "eKonsulta System" is being discontinued (Circular 2025-0077). Sources disagree on the migration deadline to a certified EMR system — either 1 July or 31 December 2026 — and this remains unconfirmed. Check directly with the relevant PhilHealth circular. 注 YAKAP is tied to the facility where a patient registers. Seeking care elsewhere may result in out-of-pocket costs.

A correction regarding outpatient mental health benefits

注 The first draft of this file stated that "starting 2026, initial psychiatric consultations would also be covered" — this is inaccurate. PhilHealth's outpatient mental health benefit package is based on Circular 2023-0018, which has existed since 2023. What is new for 2026 is rather a coverage-expansion target — requiring all YAKAP-implementing facilities to offer the mental health package (PIA). This benefit is a separate allocation from the ₱20,000/year YAKAP-GAMOT allowance and can be used alongside it.

The scale of benefits in 2026

注 ₱400 billion is a "target/annual budget ceiling," not a confirmed benefit amount. PhilHealth itself acknowledges this level would exceed projected premium and subsidy income.

6. The public-private health divide and hospital hierarchy

Hospital classification (DOH Administrative Order AO 2012-0012)

The gap, by the numbers

注 The "1.005" and "0.5" bed ratios come from the same source, DOH, but differ. The former appears to be based on total registered beds, the latter on operational/accredited beds, but which is correct has not been officially clarified (unconfirmed). Citing only the older "0.5" figure is risky.

Structural takeaway: most beds are in private facilities, and patients concentrate at large public hospitals (PGH, regional hospitals, etc.). Urban areas offer more, higher-cost options; rural areas offer fewer, and severe cases often require transfer to Manila or Cebu. This creates a geographic access gap that exists apart from whether a patient can afford care.

Access-improvement measures (2024–2026)

• BUCAS Centers (Bagong Urgent Care and Ambulatory Service): free outpatient/urgent-care facilities launched by DOH in 2024. The first opened 6 March 2024 at the Jose B. Lingad Memorial Regional General Hospital in Santo Tomas, Pampanga. 60 nationwide as of January 2026. As of June 2025 (51 sites), roughly 860,000 total patient visits had been recorded (PCO). Some are equipped with CT scanners.
• Super Health Centers: LGU-run. The difference from BUCAS is that BUCAS extends from DOH hospitals. Construction budgets are allocated under the 2026 GAA's HFEP (Health Facilities Enhancement Program).
• Zero-Balance Billing: aims for no additional charges at over 80 DOH and LGU hospitals. ₱1 billion allocated in the 2026 GAA.
• Doctors to the Barrios / Espesyalista para sa Bayan: deploys doctors to remote areas.

7. Brain drain in the health workforce

Nurses

On the claim "the world's largest exporter of nurses" 注: this is a widely repeated claim based on the absolute number of nurses sent abroad; there is no annual official ranking published by an international body. It is a phrase widely used in academic literature and industry media, but there is no confirmed public index establishing a specific "rank." The safer phrasing is "one of the world's largest exporters, by volume."

Doctors

注 (Made explicit in the second cross-check, 2026-08-25. The figures in the table above were checked arithmetically.) The table's "3.6–4 doctors per 10,000 population" is inconsistent with the same table's "about 95,000 practicing domestically."

  95,000 ÷ 112.7 million (PSA 2024 census) × 10,000 = about 8.4 per 10,000
  → this is roughly consistent with the table's alternate figure of "7.92"
  → "3.6–4" would imply only about 40,000–45,000 doctors, which does not match 95,000

"3.6–4" is likely counting only a subset of PRC-registered doctors (e.g., only those in the public sector, or a different WHO definition), but the original source could not be reached and this remains unconfirmed. 注 Writing "the Philippines has 3.6 doctors per 10,000 population, less than half the WHO-recommended 10" alongside "about 95,000 practice domestically" in the same sentence creates an internal contradiction. Neither figure has been deleted, but if both are cited together, the difference in definition must always be noted.

Why the outflow happens — pay

注 (Corrected in the third cross-check, 2026-08-25. Source: the Salary Schedule of Executive Order No. 64, s. 2024, original text on lawphil.net, cross-checked against the same salary table cited in the "Education System" resource, Section 9-1.) The previous version stated "the 2025 SG15 = about ₱36,619," but ₱36,619 is the pre-EO 64 figure (SSL V's final tranche, 2023), while the SG15 Step 1 under EO 64's 2nd tranche (2025) is ₱40,208. The neighboring "Education System" resource, Section 9-1, correctly cites the same EO 64 salary table for SG11 (₱30,024 in 2025 / ₱31,705 in 2026 / ₱33,387 in 2027), SG18 (₱53,818), and SG21 (₱73,303), and this matches the original text (SG15: ₱38,413 in 2024 / ₱40,208 in 2025 / ₱42,178 in 2026 / ₱44,148 in 2027). This file's 2026 figure of ₱42,178 is correct — only the prior-year comparison figure was wrong. 注 Because of this single error, the nurses' raise appeared as +15.2% (₱36,619→₱42,178) instead of the actual +4.9% (₱40,208→₱42,178). The impression that "government nurses' pay improved dramatically" was actually three years of raises misread as one year's worth.

注 A reversal has occurred where government hospitals now pay more than many private ones. This intensifies competition for government posts, making private hospitals — apart from the major private medical centers — especially prone to losing staff. 注 There is a catch to the SG15 figure on paper. The Filipino Nurses United (FNU) points out that many government nurses are contractual employees who, in practice, do not actually receive SG15 pay.

Legislative developments: on 15 December 2025, Senator Erwin Tulfo filed Senate Bill No. 1612, proposing to amend Section 32 of the Philippine Nursing Act (RA 9173) to raise the minimum salary grade for government nurses from SG15 to SG19. As of August 2026, it remains under deliberation.

8. Major diseases — the situation in 2026

8-1. Dengue — a sharp decline in 2026

(Sources: DOH / Philstar, 8 August 2026; DitoSaPilipinas, 22 June 2026)

By region (as of 1 August 2026): Central Luzon 16,057 cases, NCR 10,611, Calabarzon 10,320. Mandaluyong, Lapu-Lapu, Zamboanga, and others have exceeded epidemic thresholds. Cebu City reported 1,228 cases and 10 deaths as of early August.

Reasons for the decline (DOH's explanation): intensified community-level prevention and awareness. The "4 Ts" campaign (Taob / Taktak / Tuyo / Takip — turn over, tap out, dry, cover) has reduced standing water where mosquito larvae breed.

注 Still no room for complacency

  The rate of decline narrowed from -56% (Jan–May) to -46% (Jan–Aug).
    Early in the year is a naturally low-transmission period;
    the real test comes during the July–September peak season.

  The underlying structural factor — warming temperatures extending
    Aedes aegypti's breeding season beyond the traditional rainy season —
    has not changed.

  Localized outbreaks continue.

注 The first draft included a projected figure, "an average of 444,678 cases per year for 2025–2027," but this file does not adopt it because the publishing body/model name behind it could not be identified. Avoid placing model-derived projections alongside DOH's actual measured figures.

On vaccines (as of August 2026): - Qdenga (TAK-003, made by Takeda) is still under review by the Philippine FDA and has not been approved (Office of the President, 2 June 2026). The application dates back to 2023. - Government concerns: lower efficacy in the 4–5 age group than in other age groups, limited data on the DENV-3 serotype prevalent in the Philippines, and past application withdrawals in the US and Singapore. - This caution stems in part from the 2018 Dengvaxia controversy, which has made regulators extremely careful. - Globally, it is approved in more than 40 countries, and the WHO granted prequalification in May 2024.

For travelers: dengue risk is highest during the rainy season (roughly June–November). Mosquito protection (DEET/icaridin-based repellent, long sleeves, screened accommodation) and travel insurance are necessary. PhilHealth generally does not cover uninsured foreign tourists.

8-2. Tuberculosis (TB) — third-highest in the world

注 (Resolved in the third cross-check, 2026-08-25. Source: WHO / World Bank indicator SH.TBS.INCD, sourced from the WHO Global Tuberculosis Report, updated 2026-07-13.) The previous version stated that "625 and 500 are different tabulations from the same WHO report" — this was incorrect. WHO's actual estimated-incidence series runs 544–632 for 2015–2024, and the figure 500 does not appear in any year.

  625 (2024) = WHO's "estimated incidence" — the confirmed figure used in this table
  注~500      = likely the rate of "notified" (reported) cases,
                 or an old, rounded citation (original source unconfirmed)

The arithmetic also supports the 625 figure. 625/100,000 × 112.73 million (PSA 2024 census) = about 705,000 people, which is roughly consistent with the table's "6.8% of the world's cases" (against an estimated global incidence of about 10.7 million). At 500/100,000, the figure would be about 560,000 — or 5.3% of the world total — which does not match 6.8%.

注 (Corrected during the 2026-08-25 verification pass. The earlier figure of "about 10.5 million" was incorrect. Source: WHO Tuberculosis fact sheet, https://www.who.int/news-room/fact-sheets/detail/tuberculosis — "an estimated 10.7 million people fell ill with TB worldwide" (2024); 1.23 million deaths. This figure was harmonized with the "Public Health and Infectious Disease" resource, Section 3-1.)

注 On the table's "diagnostic gap of 7.5%, third after Indonesia and India": the "Public Health and Infectious Disease" resource, Section 3-2, could not reach the original source for this claim (the relevant chapter of the WHO Global Tuberculosis Report 2025) and treats it as "unconfirmed." Both figures remain, but the chapter/table number of the original source should be checked before citing either. 注 The share of cases is "India 25% > Indonesia 10%," and the reason the diagnostic-gap ranking reverses order has not been confirmed in the original source. 注 This file therefore adopts 625. "About 500" is retained rather than deleted, but it must not be cited as the estimated incidence rate. The gap between "the number diagnosed (notification)" and "the number estimated (incidence)" — the diagnostic gap — is the central issue in the Philippines' TB response, and describing these two figures as "different cuts of the same metric" erases the very issue at stake.

Countermeasures (PhilSTEP2 2025-2030 / PAAP-TB 2023-2035): - A target of screening 12 million people in 2026 (DOH + WHO, announced 12 November 2025). - The proposed 2026 TB budget is ₱4.2 billion, nearly double the ₱2.6 billion in 2025. - Introduction of ultra-portable, AI-assisted chest X-ray devices and WHO-recommended nucleic acid amplification tests (NAAT). - For drug-resistant TB, fully oral regimens have shortened treatment from 2 years to 6 months. - Enrollment in short-course preventive treatment (TPT) grew more than 50% in 2024. - TB-DOTS (free diagnosis and treatment at health centers) is in principle available to citizens and foreigners alike.

8-3. HIV — the fastest-growing epidemic in Asia-Pacific

注 (Made explicit in the second cross-check, 2026-08-25. Source: this table's DOH Epidemiology Bureau data, checked arithmetically, cross-referenced with the "Gender, LGBT & Family Law" resource, Section 9.) This table's "+9%" is inconsistent with the same table's "51/day (57/day in Q1 2025, -11%)." The arithmetic runs as follows:

  4,633 cases ÷ 90 days = 51.5/day  … matches the table's "51/day"
  If Q1 2025 was 57/day, that quarter totaled 57 × 90 = 5,130 cases
  4,633 ÷ 5,130 = -9.7%     … i.e., the year-on-year change is actually "-9%"

A sign error (+9% vs. -9%) seems most likely, but since the original DOH source (the quarterly HARP report) could not be reached, neither figure has been deleted. 注 The likely source of confusion: compared with Q4 2025 (4,277 cases), the figure is +8.3% — an increase — while compared with Q1 2025 (an estimated 5,130 cases), it is a decrease. Always confirm whether a figure is "year-on-year" or "quarter-on-quarter." The same number has been used as evidence both of "surging" and of "plateauing."

International context: - UNAIDS: "The Philippines has the fastest-growing HIV epidemic in Asia-Pacific" (June 2025). - Health Secretary Herbosa: "the highest number of new cases in the Western Pacific region." - From 13 cases/day in 2013 to 57/day — a +338% increase over 12 years. - Among youth aged 15–25, a 500% increase has been reported (DOH/PNAC). 注See note below (the age bracket and time period differ from the "Gender, LGBT & Family Law" resource).

注 (Made explicit in the fourth cross-check, 2026-08-25. Source: "Gender, LGBT & Family Law" resource, Section 9.) The same claim of "about a 500% increase among young people" appears in this cluster of resources with two different definitions.

The standard age bracket used in DOH/PNAC's epidemiological statistics (HARP) is "15–24" (this section's own table above also uses "15–24 accounts for 31%" — meaning the table and the body text within this very section disagree). 注 "15–25" appears to be a rounding used in news reporting, but the original source could not be reached and this remains unconfirmed, so neither version has been deleted. When citing this, always attach the bracket and period: "a roughly 500% increase among ages 15–24 between 2010 and 2023 (DOH/PNAC)." Stating the multiplier without the time period can read as if the increase happened fivefold within a single recent year.

Moves toward declaring a state of emergency 注: in 2025, DOH and PNAC (the Philippine National AIDS Council) recommended that President Marcos declare a "national public health emergency" under RA 11332. WHO and UNAIDS voiced support. However, as of the August 2026 research cutoff, no information could be found confirming that such a declaration has actually been signed (unconfirmed). Do not write that it has "already been declared."

Prevention: - AO 2026-0005: an administrative order on differentiated PrEP (pre-exposure prophylaxis)/PEP (post-exposure prophylaxis) service delivery. - PrEP has been added to the national drug formulary, with a government procurement goal of reaching 150,000 people. - Oral PrEP and cabotegravir are approved; lenacapavir is under review (Global PrEP Tracker, July 2026). - The legal basis is RA 11166 (the Philippine HIV and AIDS Policy Act, 2018), which provides for anti-discrimination protections, a lowered consent age for testing, and anonymous testing.

8-4. Measles/rubella and vaccination rates

Response: a supplemental measles/rubella immunization activity (MR-SIA) began in Mindanao on 19 January 2026, targeting children aged 6–59 months. The 2026 budget increased the allocation for measles/rubella vaccines. WHO has listed the Philippines among the "top 5 countries with the most 'zero-dose' children" (children who have never received a single vaccine).

8-5. Non-communicable diseases (NCDs) as the leading causes of death

Top causes of death for 2025 (PSA preliminary figures as of 30 April 2026; final figures due January 2027)

注 PSA's cause-of-death statistics are "preliminary" and are updated in stages. Even for the same year, 2025, the figure for ischemic heart disease was 100,958 as of the February 2026 cut and 122,339 as of April. Always specify the cutoff date of the preliminary figure being cited.

9. Malnutrition and obesity — a double burden

Stunting got worse

注注 The "23.6% stunting" figure that appeared in this file's original topic brief is from the 2023 National Nutrition Survey (NNS, published December 2024) — it is not the latest figure. The 2025 update survey (conducted 23 April 2025 – 31 March 2026, covering 118 provinces/highly urbanized cities and 91.5% of the target households, published June 2026) shows a rise to 25.3% — the first increase in a decade, since 2015. DOST-FNRI classifies this as a "high public health concern."

Regional gap: rural 27.8% ⇔ urban 23.2%. BARMM (36.0%) and Zamboanga Peninsula (34.6%) are worst.

注 Terminology note: "ENNS" (Expanded National Nutrition Survey) is the name used for the 2018–2021 survey rounds. In 2023 it was called "NNS," and in 2025 it was called an "Updating Survey" — the name has changed.

Meanwhile, adult obesity is surging

(Source: DOST-FNRI 2025 update survey / Rappler, BusinessWorld, GMA, 17 June 2026. Uses the Asia-Pacific BMI standard.)

Breakdown: women 50.1%, urban 48.3%, the wealthiest quintile 57.8%. By region: NCR 52.7%, CAR 50.6%, Central Luzon 49.6%. 77.5% of adolescents are physically inactive, 5.4% smoke, and 9.1% drink alcohol. About 1 in 10 adults, conversely, suffer chronic energy deficiency (more common among men).

The National Nutrition Council (NNC) in 2026 called for urgent, whole-of-society action, noting that "stunting and obesity are both worsening and falling short of the annual reduction targets under PPAN 2023-2028."

10. Mental health

Republic Act No. 11036 (the Mental Health Act) was passed in 2018. It is the Philippines' first law establishing mental health as a right, and it mandates:

• Integration of mental health services across all levels of the health system
• A 24-hour suicide-prevention hotline (Section 21)
• Promotion of community-based care
• Protection of patients' rights, informed consent, and non-discrimination
• Mental health programs in schools and workplaces

The crisis hotline (NCMH Crisis Hotline, 24 hours)

  Nationwide:        1553
  Toll-free:         1800-1888-1553
  Smart/TNT:         0919-057-1553
  Globe/TM:          0917-899-8727 / 0966-351-4518

  Hopeline Philippines (Natasha Goulbourn Foundation): (02) 8804-4673

(Opened 2 May 2019, with the tagline "Kamusta Ka?, Tara Usap Tayo")

注 The reality of implementation

Policy framework: DOH and WHO have developed the "Philippine Council for Mental Health Strategic Framework 2024-2028," built on four pillars: governance, integration into primary care, stigma reduction, and data infrastructure.

Legislative developments: a House bill from November 2025 notes that because RA 11036 does not mandate "a single, interoperable, three-digit national hotline," multiple operators have proliferated, and calls for consolidation.

Benefits: PhilHealth's outpatient mental health benefit package (Circular 2023-0018). Expanding availability at YAKAP-implementing facilities is a 2026 goal.

11. Practical information for residents and travelers (a foreigner's perspective)

11-1. Foreigners and PhilHealth

11-2. A sense of private healthcare costs (indicative only)

注 Neither St. Luke's nor Makati Medical Center publishes an official price list. The figures below are estimates compiled by private price-comparison sites in 2026, not official rates.

There is generally no "foreigner surcharge." But without PhilHealth or an HMO, the entire bill becomes out-of-pocket. Medical staff generally speak English (medical education is conducted in English).

11-3. Laws and mechanisms worth knowing

• RA 10932 (the Amended Anti-Hospital Deposit Law, 3 August 2017): it is illegal for a hospital or clinic to demand or accept a deposit or advance payment before treatment in an emergency or serious case. This also covers women in labor as part of "basic emergency care." Violations carry imprisonment of 6 months and 1 day to 2 years 4 months, or a fine of ₱100,000–300,000. Officers responsible for the policy face 4–6 years imprisonment and a fine of ₱500,000–1,000,000. A third violation revokes the facility's operating license. 注 However, it does not apply to non-emergency cases or to continued hospitalization after initial stabilization, so in practice, advance payment is often still required.
• Drug price regulation: the Maximum Drug Retail Price (MDRP) system under RA 9502. EO 104 (2020: cut prices on 87 drugs/133 formulations by up to 50%, effective 2 June 2020) and EO 155 (signed 7 December 2021, fully implemented 23 March 2022, covering 121 molecules/204 formulations, a median cut of 40% and a maximum of 93%). 注 No new EO appears to have been issued in 2025–2026 (unconfirmed). Senior citizens and PWDs receive discounts on top of the MDRP.
• Emergency number: 911 (nationwide).
• HMOs (private health insurance): as of 2026, the Insurance Commission (IC) supervises 26 companies. 2025 industry revenue was ₱101.56 billion (+24.8%), with benefit payouts of ₱74.64 billion. Q1 2026 net income was ₱818.7 million (+41%) (IC / Inquirer, Manila Bulletin). 注 Medical inflation is high — WTW's survey projected the Philippines' 2025 medical cost trend at 18.3%, second-highest in Asia-Pacific. Assume premiums will rise every year. 注 Caritas Health Shield entered liquidation proceedings and stopped accepting new members as of 18 August 2025.
• HMO pitfalls: depending on plan tier, some hospitals may not be usable (e.g., some plans exclude St. Luke's BGC entirely, or cover it for emergencies only). Always confirm the covered hospital network and plan tier before enrolling or before admission.

12. Medical tourism

Market size — 注 all figures are private-sector research estimates

注 Even for roughly the same period, figures range from US$1.26–1.7 billion. These are private-sector estimates using different methodologies, not confirmed government statistics. Always name the research firm when citing them.

Annual medical tourists: an estimated 80,000–250,000 (a wide range, and not a confirmed government figure).

注Fact-checking claims of "world rank"

Conclusion: "a top-ranked medical tourism destination in the world" should be avoided, since neither the index nor the year can be pinned down. If used, attribute it explicitly: "the Tourism Department describes the Philippines as 3rd in Southeast Asia and top 20 globally (a government claim)."

Internationally accredited (JCI) hospitals

注 Sources disagree on whether there are 4 or 5 such facilities (unconfirmed). Those commonly cited are:

For comparison: Thailand has 62 JCI-accredited hospitals (2024, a Philstar column). The Philippines' weak point is not the quality of any single hospital but the depth of the surrounding ecosystem.

Cost advantage and strengths

• Roughly 40–80% cheaper than the US, UK, or Australia (estimates vary). 注 Individual figures cited in the original brief — "US$17,000–19,000 for heart bypass surgery," "US$23,000–25,000 for a kidney transplant" — are industry-site benchmarks, not official prices (unconfirmed). If used, label them as "industry benchmark figures."
• English-speaking medical staff, modern facilities in Manila, Cebu, and Davao, and the ability to pair treatment with a resort stay.
• The largest segment is cosmetic surgery (about 35% in 2025), followed by dentistry (implants and orthodontics). Fertility treatment (IVF) is projected to be the fastest-growing segment (PS Market Research).
• The Department of Tourism (DOT), working with the Department of Health (DOH), has set a long-term goal of 1 million annual medical/wellness tourists.

13. Glossary of terms and abbreviations

日本語の詳細版: 分野「社会・人権・治安」「医療と健康」（本サイト日本語版）。